NO991569L - Flytende alendronatforbindelser - Google Patents

Flytende alendronatforbindelser

Info

Publication number: NO991569L
Authority: NO; Norway
Prior art keywords: liquid; compounds; preparation; liquid alendronate; alendronate compounds
Prior art date: 1996-10-04

Application number

NO991569A

Other languages

English (en)

Norwegian (no)

Other versions

NO991569D0 (no

Inventor

Maneesh J Nerurkar

William H Hunke

Drazen Ostovic

Original Assignee

Merck & Co Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-10-04

Filing date

1999-03-30

Publication date

1999-06-04

1997-01-13 Priority claimed from GBGB9700541.7A external-priority patent/GB9700541D0/en

1999-03-30 Application filed by Merck & Co Inc filed Critical Merck & Co Inc

1999-03-30 Publication of NO991569D0 publication Critical patent/NO991569D0/no

1999-06-04 Publication of NO991569L publication Critical patent/NO991569L/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Physical Education & Sports Medicine (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Rheumatology (AREA)
Epidemiology (AREA)
Orthopedic Medicine & Surgery (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO991569A 1996-10-04 1999-03-30 Flytende alendronatforbindelser NO991569L (no)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US2676596P	1996-10-04	1996-10-04
GBGB9700541.7A GB9700541D0 (en)	1997-01-13	1997-01-13	Liquid alendronate formulation
US3600297P	1997-01-22	1997-01-22
PCT/US1997/015740 WO1998014196A1 (en)	1996-10-04	1997-10-02	Liquid alendronate formulations

Publications (2)

Publication Number	Publication Date
NO991569D0 NO991569D0 (no)	1999-03-30
NO991569L true NO991569L (no)	1999-06-04

Family

ID=27268667

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO991569A NO991569L (no)	1996-10-04	1999-03-30	Flytende alendronatforbindelser

Country Status (20)

Country	Link
EP (1)	EP1007054A4 (xx)
JP (1)	JP2001501222A (xx)
CN (1)	CN1238691A (xx)
AU (1)	AU723357B2 (xx)
BG (1)	BG103306A (xx)
BR (1)	BR9712197A (xx)
CA (1)	CA2267370A1 (xx)
CZ (1)	CZ116999A3 (xx)
EA (1)	EA001213B1 (xx)
EE (1)	EE03669B1 (xx)
HU (1)	HUP0000125A3 (xx)
IL (1)	IL129127A0 (xx)
IS (1)	IS5012A (xx)
NO (1)	NO991569L (xx)
NZ (1)	NZ334836A (xx)
PL (1)	PL332496A1 (xx)
SK (1)	SK42999A3 (xx)
TR (1)	TR199900730T2 (xx)
WO (1)	WO1998014196A1 (xx)
YU (1)	YU17499A (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7560490B2 (en)	2001-01-23	2009-07-14	Gador S.A.	Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition and use thereof
US7645460B2 (en)	2004-05-24	2010-01-12	The Procter & Gamble Company	Dosage forms of risedronate
US7645459B2 (en)	2004-05-24	2010-01-12	The Procter & Gamble Company	Dosage forms of bisphosphonates
US20080287400A1 (en)	2004-05-24	2008-11-20	Richard John Dansereau	Low Dosage Forms Of Risedronate Or Its Salts
US20080286359A1 (en)	2004-05-24	2008-11-20	Richard John Dansereau	Low Dosage Forms Of Risedronate Or Its Salts
US7473684B2 (en)	2005-09-16	2009-01-06	Selamine Limited	Bisphosphonate formulation
WO2007031785A2 (en) *	2005-09-16	2007-03-22	Selamine Ltd	Bisphosphonate formulation
JP2010043119A (ja) *	2009-10-16	2010-02-25	Gador Sa	骨の代謝病の予防および／または治療のための組成物、その組成物の調製方法およびその使用
US8568747B1 (en)	2012-10-05	2013-10-29	Silvergate Pharmaceuticals, Inc.	Enalapril compositions
US9463183B1 (en)	2015-10-30	2016-10-11	Silvergate Pharmaceuticals, Inc.	Lisinopril formulations
US9669008B1 (en)	2016-03-18	2017-06-06	Silvergate Pharmaceuticals, Inc.	Enalapril formulations

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4206209A (en) *	1978-11-02	1980-06-03	Kracauer Paul	Sublingual aspirin tablet
IT1201087B (it) *	1982-04-15	1989-01-27	Gentili Ist Spa	Bifosfonati farmacologicamente attivi,procedimento per la loro preparazione e relative composizioni farmaceutiche
US4922007A (en) *	1989-06-09	1990-05-01	Merck & Co., Inc.	Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or salts thereof
US5019651A (en) *	1990-06-20	1991-05-28	Merck & Co., Inc.	Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid (ABP) or salts thereof
US5270365A (en) *	1991-12-17	1993-12-14	Merck & Co., Inc.	Prevention and treatment of periodontal disease with alendronate
US5358941A (en) *	1992-12-02	1994-10-25	Merck & Co., Inc.	Dry mix formulation for bisphosphonic acids with lactose
FR2703590B1 (fr) *	1993-04-05	1995-06-30	Sanofi Elf	Utilisation de derives d'acide bisphosphonique pour la preparation de medicaments destines a favoriser la reparation osseuse .
US5510517A (en) *	1993-08-25	1996-04-23	Merck & Co., Inc.	Process for producing N-amino-1-hydroxy-alkylidene-1,1-bisphosphonic acids
US5462932A (en) *	1994-05-17	1995-10-31	Merck & Co., Inc.	Oral liquid alendronate formulations
US5780455A (en) *	1994-08-24	1998-07-14	Merck & Co., Inc.	Intravenous alendronate formulations
US5616571A (en) *	1995-06-06	1997-04-01	Merck & Co., Inc.	Bisphosphonates prevent bone loss associated with immunosuppressive therapy

1997
- 1997-10-02 EA EA199900352A patent/EA001213B1/ru not_active IP Right Cessation
- 1997-10-02 TR TR1999/00730T patent/TR199900730T2/xx unknown
- 1997-10-02 NZ NZ334836A patent/NZ334836A/xx unknown
- 1997-10-02 HU HU0000125A patent/HUP0000125A3/hu unknown
- 1997-10-02 SK SK429-99A patent/SK42999A3/sk unknown
- 1997-10-02 BR BR9712197-5A patent/BR9712197A/pt unknown
- 1997-10-02 CN CN97180165A patent/CN1238691A/zh active Pending
- 1997-10-02 CZ CZ991169A patent/CZ116999A3/cs unknown
- 1997-10-02 PL PL97332496A patent/PL332496A1/xx unknown
- 1997-10-02 EE EEP199900113A patent/EE03669B1/xx not_active IP Right Cessation
- 1997-10-02 IL IL12912797A patent/IL129127A0/xx unknown
- 1997-10-02 JP JP10516541A patent/JP2001501222A/ja active Pending
- 1997-10-02 CA CA002267370A patent/CA2267370A1/en not_active Abandoned
- 1997-10-02 WO PCT/US1997/015740 patent/WO1998014196A1/en not_active Application Discontinuation
- 1997-10-02 EP EP97945195A patent/EP1007054A4/en not_active Withdrawn
- 1997-10-02 AU AU46448/97A patent/AU723357B2/en not_active Ceased
1999
- 1999-03-26 IS IS5012A patent/IS5012A/is unknown
- 1999-03-30 NO NO991569A patent/NO991569L/no not_active Application Discontinuation
- 1999-03-31 YU YU17499A patent/YU17499A/sr unknown
- 1999-04-02 BG BG103306A patent/BG103306A/xx unknown

Also Published As

Publication number	Publication date
CZ116999A3 (cs)	1999-09-15
EA001213B1 (ru)	2000-12-25
CA2267370A1 (en)	1998-04-09
JP2001501222A (ja)	2001-01-30
NO991569D0 (no)	1999-03-30
AU723357B2 (en)	2000-08-24
IL129127A0 (en)	2000-02-17
EA199900352A1 (ru)	1999-08-26
HUP0000125A2 (hu)	2000-06-28
YU17499A (en)	1999-11-22
BG103306A (en)	2000-01-31
HUP0000125A3 (en)	2001-04-28
BR9712197A (pt)	1999-08-31
AU4644897A (en)	1998-04-24
EE03669B1 (et)	2002-04-15
CN1238691A (zh)	1999-12-15
PL332496A1 (en)	1999-09-13
EP1007054A4 (en)	2000-07-19
EE9900113A (et)	1999-10-15
SK42999A3 (en)	2000-01-18
NZ334836A (en)	2000-11-24
TR199900730T2 (xx)	1999-07-21
EP1007054A1 (en)	2000-06-14
IS5012A (is)	1999-03-26
WO1998014196A1 (en)	1998-04-09

Similar Documents

Publication	Publication Date	Title
NO991569L (no)	1999-06-04	Flytende alendronatforbindelser
ES2082723B1 (es)	1996-10-01	Formulacion farmaceutica de fluoxetina en forma dispersable.
NO943888L (no)	1995-04-18	Farmasöytisk preparat
IS2788B (is)	2012-06-15	Búdesóníð- / formóterólefnablanda til innöndunar með lausa þéttni frá 0,30 til 0,36 g/ml, aðferð við að framleiða efnablönduna og notkun hennar
MY154010A (en)	2015-04-30	Rapidly disintegrable solid preparation
DK0850046T3 (da)	2003-03-03	Mikroemulsioner til anvendelse som vhikel til indgift af active forbindelser
NO20053076L (no)	2005-09-13	Farmasoytisk formulering med en uloselig aktiv forbindelse.
CA2213996A1 (en)	1997-07-17	Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate
NO20032773D0 (no)	2003-06-18	Farmasöytisk preparat som omfatter pyrsazolo [4,3-d] pyrimidiner og antitrombotika, kalsiumantagonister, prostaglandiner ellerprostaglandinderivater
NO20024733D0 (no)	2002-10-02	Hydrofile molekyl¶rdisperse lösninger av karvedilol
SE0101379D0 (sv)	2001-04-18	Komposition som hämmar utsöndring av magsyra
RS50089B (sr)	2009-01-22	Suspenzija ziprasidona
NO20051190L (no)	2005-04-08	Kronoterapeutiske diltiazem-formuleringer og administrering av disse
PT1425005E (pt)	2006-09-29	Composicao farmaceutica que compreende lumiracoxib
CA2503154A1 (en)	2004-05-06	A new crystalline form of the sodium salt of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid
CA2242224A1 (fr)	1997-07-03	Microgranules a liberation prolongee contenant du diltiazem comme principe actif
ATE201680T1 (de)	2001-06-15	2,3,4,5-tetrahydro-1h-3-benzazepin säure- additions-salze
HUP9900227A2 (hu)	2000-03-28	AII-receptor antagonisták új gyógyszerészeti felhasználása
ATE172770T1 (de)	1998-11-15	Stabknoten
HRP20010764B1 (en)	2011-01-31	Prucalopride oral solution
NO961242D0 (no)	1996-03-27	Fremgangsmåte for fremstilling av faste dispersjoner og depoter såvel som faste medisinske former med dihydropyridin-type kalsium-antagonister
NZ334949A (en)	2000-12-22	Stabilised pharmaceutical composition of quinupristine and dalfopristine with methanesulphonic acid or hydrochloric acid
RO115414B1 (ro)	2000-02-28	Compoziţie farmaceutică, intranazală
RU99102949A (ru)	2000-12-10	Препарат "антигриппин"
MXPA03005441A (es)	2003-09-10	Formulacion farmaceutica que contiene tienopirimidinas y antitromboticos, antagonistas de calcio, prostaglandinas o derivados de prostaglandina (2).

Legal Events

Date	Code	Title	Description
2003-03-03	FC2A	Withdrawal, rejection or dismissal of laid open patent application